Bayview Pharmacy is pleased to provide a specially compounded injection solution containing Alprostadil ranging from 5 mcg/ml to 45 mcg/ml, Papaverine HCl from 15 mg/ml to 30 mg/ml, and Phentolamine Mesylate from 0.4 mg/ml to 5 mg/ml. This unique formulation is designed to address a variety of health conditions, including erectile dysfunction, Raynaud's phenomenon, and hypertensive crises.

Alprostadil is a potent vasodilator that works by relaxing the smooth muscle in the penis, thereby enhancing blood flow and improving erectile function. Papaverine HCl, a smooth muscle relaxant, operates in a similar manner, promoting increased blood flow and improved erectile function. Phentolamine Mesylate, an alpha-adrenergic blocker, mitigates the effects of vasoconstriction, further facilitating improved blood flow and erectile function.

This compounded injection solution is a highly effective treatment option for erectile dysfunction, Raynaud's phenomenon, and hypertensive crises. It is crucial to understand that this formulation should only be administered under the guidance of a healthcare provider. If you have any queries or require further information about this formulation, please do not hesitate to contact us at Bayview Pharmacy.

The medication is contained in a small glass container designed to hold sterile liquid medication, typically administered through injection using a syringe. A syringe is inserted into the container and filled to the desired amount for accurate dosing. This method ensures the precise delivery of the medication, contributing to its efficacy and safety.

Alprostadil, Papaverine HCl, and Phentolamine Mesylate injection solution is a compounded formulation designed for the treatment of erectile dysfunction and Peyronie's disease. This potent combination of medications works synergistically to increase blood flow to the penis, facilitating an erection. Alprostadil, a prostaglandin, Papaverine HCl, an antispasmodic, and Phentolamine Mesylate, an alpha-adrenergic blocker, all contribute to the relaxation of smooth muscle cells.

Peyronie's disease, a condition characterized by the curvature of the penis due to scar tissue, can also be treated with this medication. The combined effect of these medications can help alleviate the symptoms of this condition.

Patients should be informed that this medication may cause side effects such as dizziness, flushing, headache, and nausea. A prolonged erection, which can be painful and necessitate medical attention, may also occur. It is crucial that patients do not take this medication if they are currently on nitrates or alpha-blockers, as these can cause a dangerous drop in blood pressure when combined with this medication.

Prescribers should exercise caution when prescribing this medication. It should not be used in patients with a history of heart disease, stroke, or blood clots. Additionally, patients with a history of priapism, a condition characterized by a prolonged and painful erection, should avoid this medication. Patients with a history of liver or kidney disease should also avoid this medication, as it can lead to an increase in side effects.

If you have any questions about this formulation or its application in treating these disease states, please do not hesitate to reach out for further information.

Alprostadil 5 Mcg/ml To 45 Mcg/ml/Papaverine HCl 15 mg/ml To 30 mg/ml/Phentolamine Mesylate 0.4 mg/ml To 5 mg/ml Injection Solution is a compounded formulation designed to treat erectile dysfunction. This solution combines three active ingredients: Alprostadil, Papaverine HCl, and Phentolamine Mesylate.

Alprostadil is a potent vasodilator that works by relaxing the muscles in the penis, thereby facilitating increased blood flow and enabling an erection. The dose range for Alprostadil in this formulation is 5 to 45 mcg/ml.

Papaverine HCl, like Alprostadil, is a vasodilator that aids in relaxing the penile muscles, promoting increased blood flow and contributing to the achievement of an erection. The dose range for Papaverine HCl in this formulation is 15 to 30 mg/ml.

Phentolamine Mesylate is an alpha-adrenergic blocker. Its role in this formulation is to prevent the body from reabsorbing the blood that has been released into the penis, thereby allowing for a longer-lasting erection. The dose range for Phentolamine Mesylate in this formulation is 0.4 to 5 mg/ml.

This combination of medications is administered via direct injection into the penis. The dosage is adjusted based on the patient's response to the treatment. It is important to note that the use of this formulation should be under the guidance of a healthcare professional. If you have any questions about this formulation or its mechanism of action, please consult your healthcare provider.

This compounded formulation of Alprostadil 5 Mcg/ml To 45 Mcg/ml/Papaverine HCl 15 mg/ml To 30 mg/ml/Phentolamine Mesylate 0.4 mg/ml To 5 mg/ml Injection Solution is a versatile medication used in the treatment of a variety of conditions. Primarily, it is used to address erectile dysfunction, Peyronie's disease, priapism, Raynaud's syndrome, and vasospasm. It also has applications in the treatment of ischemic ulcers, chronic venous insufficiency, and thrombophlebitis. Beyond these, it has been found effective in managing post-surgical pain, post-traumatic pain, and post-radiation pain. This formulation has also been used to alleviate chronic pain associated with cancer, peripheral neuropathy, fibromyalgia, and rheumatoid arthritis. If you have any questions about the use of this formulation, please reach out for further information.